Independence iBOT 3000/4000 Mobility System
by Independence Technology, LLC
PMA P020033
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPRL | NumberP020033 | Date13 Aug 2003 | StatusActive |
Recalls
-
- Terminated Z-1775-2010
A thermal breaker in the battery pack has the potential to open due to overheating and disable one third of the cells in the affected battery pack.
-
- Terminated Z-0022-05
Rocks and debris can enter into the wheel cluster housing through a damaged wheel cap causing wheel malfunction.
-
- Terminated Z-1383-04
iBOT Mobility System may tip over due to malfunction in power base.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Full name
- Independence (Tm) Ibot 3000/4000 Mobility System
- Generic Name
- Wheelchair, stair climbing
- PMA Number
- FDA Product Code
- IMK
- Device Class
- Class II
- Regulation
- 21 CFR Part 890.3890
- Advisory Committee
- Physical Medicine
- FDA Decision
- APRL
Overview
AI-generated summary, 18 Sep 2026
The Independence iBOT 3000/4000 Mobility System is a Wheelchair, Stair Climbing (per FDA nomenclature), designed for individuals with mobility impairments who retain the use of at least one upper extremity. It provides active mobility assistance through dynamic balancing and propulsion, enabling movement across varied surfaces, inclines, obstacles, and staircases—both independently and with assistance—while also facilitating seated mobility at elevated heights and transportation of the unoccupied device.
This system is intended for use in home, work, and other environments, offering up to five primary operating functions: smooth-surface mobility, obstacle/terrain navigation, seated elevation mobility, stair ascent/descent (with or without assistance), and unoccupied transport. Supplied as a reusable, non-sterile Class II device under FDA_PMA (P020033), it adheres to IMK product coding and 890.3890 regulatory standards. No MRI safety or sterility requirements are specified, and sizing is determined by user-specific anthropometric measurements for proper fit and function.
Other devices from Independence Technology, LLC
Questions
AI-generated answers, 18 Sep 2026
What types of environments is the Independence iBOT 3000/4000 Mobility System designed to operate in?
The Independence iBOT 3000/4000 Mobility System is specifically designed for use in a variety of environments, including homes, workplaces, and other everyday settings. It is engineered to provide mobility assistance across smooth surfaces, inclines, obstacles, uneven terrain, and staircases—both independently and with assistance—while also enabling seated mobility at elevated heights and allowing the unoccupied device to be transported.
How is the Independence iBOT 3000/4000 Mobility System sized for users?
Sizing for the Independence iBOT 3000/4000 Mobility System is determined by user-specific anthropometric measurements to ensure proper fit and function. This means the device is tailored to the individual’s body dimensions rather than using standardized sizes, allowing for optimal performance and comfort.
Is the Independence iBOT 3000/4000 Mobility System intended for single-use or reusable applications?
The Independence iBOT 3000/4000 Mobility System is supplied as a reusable device. It is classified as a non-sterile Class II medical device under FDA_PMA, meaning it is designed for repeated use by the same user over time, provided it is properly maintained and cleaned as recommended.
What are the primary functions of the Independence iBOT 3000/4000 Mobility System?
The Independence iBOT 3000/4000 Mobility System offers up to five primary operating functions: smooth-surface mobility, obstacle and terrain navigation (including grass, gravel, and curbs), seated elevation mobility, stair ascent and descent (with or without assistance), and the ability to transport the unoccupied device. These functions collectively aim to enhance active mobility for users with mobility impairments who retain the use of at least one upper extremity.
What regulatory pathway was followed for the approval of the Independence iBOT 3000/4000 Mobility System?
The Independence iBOT 3000/4000 Mobility System was approved through the FDA’s Premarket Approval (PMA) process, indicated by the PMA number P020033. This pathway is typically used for higher-risk medical devices, and the device falls under the product code IMK and regulatory standard 890.3890, aligning with its classification as a Wheelchair, Stair Climbing.